References
- Eber SW, Gonzale JM, Lux ML, et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet. 1996;13(2):214–218. doi: 10.1038/ng0696-214
- Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372(9647):1411–1426. doi: 10.1016/S0140-6736(08)61588-3
- Wang C, Cui Y, Li Y, et al. A systematic review of hereditary spherocytosis reported in Chinese biomedical journals from 1978 to 2013 and estimation of the prevalence of the disease using a disease model. Intractable Rare Dis Res. 2015;4(2):76–81. doi: 10.5582/irdr.2015.01002
- Narla J, Mohandas N. Red cell membrane disorders. Int J Lab Hematol. 2017;39(Suppl.1):47–52. doi: 10.1111/ijlh.12657
- Agarwal AM. Ankyrin mutations in hereditary spherocytosis. Acta Haematol. 2019;141(2):63–64. doi: 10.1159/000495339
- Christensen RD, Yaish HM, Gallagher PG. A pediatrician’s practical guide to diagnosing and treating hereditary spherocytosis in neonates. Pediatrics. 2015;135(6):1107–1114. doi: 10.1542/peds.2014-3516
- He BJ, Liao L, Deng ZF, et al. Molecular genetic mechanisms of hereditary spherocytosis: current perspectives. Acta Haematol. 2018;139(1):60–66. doi: 10.1159/000486229
- Gallagher PG. Hematologically important mutations: ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis. 2005;35(3):345–347. doi: 10.1016/j.bcmd.2005.08.008
- Lambert S, Yu H, Prchal JT, et al. cDNA sequence for human erythrocyte ankyrin. Proc Natl Acad Sci USA. 1990;87(5):1730–1734. doi: 10.1073/pnas.87.5.1730
- Salas PC, Rosales JML, Milla CP, et al. A novel mutation in the beta-spectrin gene causes the activation of a cryptic 5′-splice site and the creation of a de novo 3′-splice site. Hum Genome Var. 2015;2:15029. doi: 10.1038/hgv.2015.29
- Bianchi P, Fermo E, Vercellati C, et al. Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica. 2012;97(4):516–523. doi: 10.3324/haematol.2011.052845
- Eber S, Lux SE. Hereditary spherocytosis – defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol. 2004;41(2):118–141. doi: 10.1053/j.seminhematol.2004.01.002
- Morle L, Bozon M, Alloisio N, et al. Ankyrin Bugey: a de novo deletional frameshift variant in exon 6 of the ankyrin gene associated with spherocytosis. Am J Hematol. 1997;54(3):242–248. doi: 10.1002/(SICI)1096-8652(199703)54:3<242::AID-AJH11>3.0.CO;2-F
- Miya K, Shimojima K, Sugawara M, et al. A de novo interstitial deletion of 8p11.2 including ANK1 identified in a patient with spherocytosis, psychomotor developmental delay, and distinctive facial features. Gene. 2012;506(1):146–149. doi: 10.1016/j.gene.2012.06.086
- Iolascon A, Avvisati RA. Genotype/phenotype correlation in hereditary spherocytosis. Haematologica. 2008;93(9):1283–1288. doi: 10.3324/haematol.13344
- Bogusławska DM, Heger E, Sikorski AF. Molecular mechanism of hereditary spherocytosis. Pol Merkur Lekarski. 2006;20(115):112–116.
- Luo Y, Li Z, Huang L, et al. Spectrum of ankyrin mutations in hereditary spherocytosis: a case report and review of the literature. Acta Haemotol. 2018;140:77–86. doi: 10.1159/000492024
- Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood Rev. 2007;21(1):1–20. doi: 10.1016/j.blre.2006.03.005
- Shin S, Jang W, Kim M, et al. Targeted next-generation sequencing identifies a novel nonsense mutation in SPTB for hereditary spherocytosis. Medicine. 2018;97:S3–S8. doi: 10.1097/MD.0000000000009218
- Bolton-Maggs PH, Langer JC, Iolascon A, et al. Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update. Br J Haematol. 2012;156(1):37–49. doi: 10.1111/j.1365-2141.2011.08921.x
- Manciu S, Matei E, Trandafir B. Hereditary spherocytosis - diagnosis, Surgical treatment and outcomes. a literature review. Chirurqia(Bucur). 2017;112(2):110–116.